drug
insulin degludec LA
Marketedupdated 3mo agoby Novo Nordisk Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3indications
investigational
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying insulin degludec LA
- phase3A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
- phase1A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
- phase2Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
- phase3Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
- phase1A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
- phase1A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
- —A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level
- —Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that